“Recently, Investigational Drug Services (IDS) at the Barbara Ann Karmanos Cancer Institute converted from paper documentation to Vestigo. At that time, we had more than 400 open and active protocols. The Vestigo team worked closely with us to prepare for the conversion, and the training and preparation took approximately four months. The Vestigo team uploaded our current inventory, and we were able to verify all data in the system before implementation. We decided to go with the “big bang” and convert all 400 protocols at once. The results were fantastic: we had the entire inventory loaded into Vestigo and were ready to go on Monday morning. We haven’t looked back since!
The transition could not have happened at a better time. The COVID-19 pandemic hit the Detroit area hard, and we had to switch to all remote monitoring visits. Without Vestigo, we would have had to upload paper drug accountability records, shipping receipts, training documents and temperature data for each remote visit request.
With Vestigo in place, we were able to easily handle the increased demand for remote visits. In addition, the drug accountability records generated from the Vestigo system are clean, easy to read and accurate. The inclusion of temperature monitoring and competency documentation within the system makes Vestigo a complete IDS solution. We have saved immense time and effort as a result of our conversion to Vestigo.”
“Pro-tip to sites who want to maximize efficiency, get Vestigo, and let the monitors log in remotely. The 2-hour reconciliation visits will drop to less than 15-minutes. The only time I need more than 20-minutes in the pharmacy is if they don’t use Vestigo…”
“At Emory University, we purchased Vestigo® in 2007. In early 2008, the University began to require that the Investigational Drug Service manages all drug studies. We quickly grew from 120 protocols to 250 in the first two years. We could not have handled the growth without Vestigo®, and our number of protocols has continued to increase to over 400 today. In addition to drug accountability and protocol management, the system has streamlined our billing process so that we can cover all operating costs. The McCreadie Group has been very responsive to ours and other users’ needs in providing frequent upgrades. They have also become an essential partner with the IDS community in helping meet the requirements of sponsors and government agencies, including the FDA. Our operation could not function without it.”
“Before coming to Tampa General, I was the IDS Team Lead of a staff of 9, and was involved with the implementation of Vestigo® at another site. We had never employed an electronic system and used sponsor supplied or other paper forms for over 300 studies. It was an incredible mess. Six months after switching to Vestigo®, every person in the IDS Team frequently said the same thing “How did we ever manage without Vestigo®?” When interviewing for my current position at Tampa General, I discussed the need for Vestigo®, and that is was essential for any IDS to function efficiently. Yes, we have now implemented Vestigo®, and all is running smoothly. I have been through several NCI and FDA audits using Vestigo®. There was never a question about the documentation or accuracy of data. Auditors always commented that it was so nice to review such “clean” data.”
